Active Biotech AB (publ) (STO:ACTI)

Active Biotech AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	65.1	27.4	36.22	41.8	53.13
Cash & Short-Term Investments	65.1	27.4	36.22	41.8	53.13
Cash Growth	137.63%	-24.36%	-13.35%	-21.34%	102.70%
Other Receivables	1.4	9.5	1.26	0.95	1.19
Receivables	1.4	9.5	1.26	0.95	1.19
Prepaid Expenses	1.08	2.32	1.24	1.38	1.53
Total Current Assets	67.58	39.21	38.71	44.12	55.86
Property, Plant & Equipment	2.02	3.35	4.72	6.26	0.95
Other Intangible Assets	0.25	0.25	0.25	0.25	-
Other Long-Term Assets	0.38	0.38	0.38	0.38	0
Total Assets	70.21	43.18	44.05	51.01	56.8
Accounts Payable	4.92	1.45	3.17	3.53	2.76
Accrued Expenses	7.68	5.44	5.36	6.37	5.98
Current Portion of Leases	1.61	1.65	1.55	1.61	0.76
Other Current Liabilities	0.28	0.36	0.3	0.56	0.41
Total Current Liabilities	14.47	8.91	10.38	12.06	9.9
Long-Term Leases	0.13	1.53	3	4.43	0.23
Total Liabilities	14.6	10.44	13.38	16.49	10.13
Common Stock	13.61	6.35	1.87	1.37	1.13
Additional Paid-In Capital	3,562	3,509	3,472	3,431	3,386
Retained Earnings	-3,520	-3,483	-3,443	-3,398	-3,340
Shareholders' Equity	55.61	32.74	30.67	34.51	46.67
Total Liabilities & Equity	70.21	43.18	44.05	51.01	56.8
Total Debt	1.74	3.18	4.55	6.04	0.99
Net Cash (Debt)	63.36	24.21	31.67	35.76	52.15
Net Cash Growth	161.72%	-23.56%	-11.42%	-31.43%	115.38%
Net Cash Per Share	0.05	0.06	0.12	0.15	0.24
Filing Date Shares Outstanding	2,636	1,230	361.74	264.89	217.97
Total Common Shares Outstanding	2,636	1,066	361.74	264.89	217.97
Working Capital	53.11	30.3	28.33	32.06	45.95
Book Value Per Share	0.02	0.03	0.08	0.13	0.21
Tangible Book Value	55.37	32.5	30.42	34.27	46.67
Tangible Book Value Per Share	0.02	0.03	0.08	0.13	0.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.